Around the Markets - ZolpiMist is TGA Approved! Interview with SUDA Pharmaceuticals CEO and Managing Director Michael Baker

Tuesday, August 4, 2020 11:57 PM +00:00

SUDA PHARMACEUTICALS LTD
Boardroom.Media
Michael Baker
Will Canty

This week in Around the Markets, Boardroom.Media CEO William Canty speaks with SUDA Pharmaceuticals CEO and Managing Director Michael Baker about the latest company news regarding TGA approval and capital raising.


Leave a Comment

Your email address will not be published

WEBCAST Calendar

  • 3 Aug

    00:00

    Merck & Co., Inc., Q2 2020 Earnings Call - July 31, 2020

    MERCK & COMPANY
  • 3 Aug

    00:30

    Colgate-Palmolive Company 2020 2Q Earnings Conference Call Webcast 31 July 2020

    COLGATE-PALMOLIVE COMPANY
  • 3 Aug

    00:30

    Q2 2020 Caterpillar Inc. Earnings Conference Call 31 July 2020

    CATERPILLAR
  • 3 Aug

    00:30

    2Q20 Charter Investor Conference Call 31 July 2020

    CHARTER COMMUNICATIONS
  • 3 Aug

    00:30

    Second Quarter 2020 Earnings Call 31 July 2020

    EXXON MOBIL CORPORATION